New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
Authors
Keywords
Coronavirus, COVID-19, COVID-19 vaccines, Diagnosis, Multiple sclerosis, SARS-CoV-2, Vaccination
Journal
JOURNAL OF NEUROIMMUNOLOGY
Volume 362, Issue -, Pages 577785
Publisher
Elsevier BV
Online
2021-12-10
DOI
10.1016/j.jneuroim.2021.577785
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach
- (2021) Aleena Banerji et al. Journal of Allergy and Clinical Immunology-In Practice
- COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
- (2021) Anat Achiron et al. Multiple Sclerosis Journal
- Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel
- (2021) Itay Lotan et al. EUROPEAN JOURNAL OF NEUROLOGY
- COVID-19 mRNA vaccination leading to CNS inflammation: a case series
- (2021) Mahsa Khayat-Khoei et al. JOURNAL OF NEUROLOGY
- Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report
- (2021) Giorgia T. Maniscalco et al. Frontiers in Neurology
- Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
- (2021) Juichi Fujimori et al. JOURNAL OF NEUROIMMUNOLOGY
- Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases
- (2021) Itay Lotan et al. Multiple Sclerosis and Related Disorders
- Multiple sclerosis following SARS-CoV-2 infection
- (2020) M. Palao et al. Multiple Sclerosis and Related Disorders
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Immune Mediated Adverse Reactions to Vaccines
- (2019) Cosby A. Stone et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Vaccination in Multiple Sclerosis: Friend or Foe?
- (2019) Tobias Zrzavy et al. Frontiers in Immunology
- Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
- (2019) Amit Bar-Or et al. TRENDS IN MOLECULAR MEDICINE
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Vaccine-preventable diseases, vaccines and Guillain-Barre’ syndrome
- (2018) Nicola Principi et al. VACCINE
- Multiple sclerosis
- (2018) Massimo Filippi et al. Nature Reviews Disease Primers
- Viral-induced suppression of self-reactive T cells: Lessons from neurotropic coronavirus-induced demyelination
- (2017) Carine Savarin et al. JOURNAL OF NEUROIMMUNOLOGY
- Vaccines and multiple sclerosis: a systematic review
- (2016) Mia Topsøe Mailand et al. JOURNAL OF NEUROLOGY
- Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases
- (2014) Annette Langer-Gould et al. JAMA Neurology
- Transverse myelitis and vaccines: a multi-analysis
- (2009) N. Agmon-Levin et al. LUPUS
- Multiple sclerosis immunology: The healthy immune system vs the MS immune system
- (2009) L. H. Kasper et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now